S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in
NASDAQ:IRTC

iRhythm Technologies Stock Forecast, Price & News

$160.90
+13.17 (+8.91 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$143.63
Now: $160.90
$163.36
50-Day Range
$147.73
MA: $203.26
$268.46
52-Week Range
$56.54
Now: $160.90
$286.19
Volume1.08 million shs
Average Volume695,824 shs
Market Capitalization$4.65 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.68
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.
iRhythm Technologies logo

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700
Employees997
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share

Profitability

Net Income$-54,570,000.00

Miscellaneous

Market Cap$4.65 billion
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.57 out of 5 stars

Medical Sector

373rd out of 1,962 stocks

Surgical & Medical Instruments Industry

35th out of 168 stocks

Analyst Opinion: 4.3Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$160.90
+13.17 (+8.91 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iRhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

Is iRhythm Technologies a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" iRhythm Technologies stock.
View analyst ratings for iRhythm Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than iRhythm Technologies?

Wall Street analysts have given iRhythm Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iRhythm Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is iRhythm Technologies' next earnings date?

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for iRhythm Technologies
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) released its quarterly earnings data on Thursday, February, 25th. The company reported ($0.33) earnings per share for the quarter, missing analysts' consensus estimates of ($0.31) by $0.02. iRhythm Technologies had a negative net margin of 20.97% and a negative trailing twelve-month return on equity of 28.89%.
View iRhythm Technologies' earnings history
.

How has iRhythm Technologies' stock been impacted by COVID-19 (Coronavirus)?

iRhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IRTC stock has increased by 88.1% and is now trading at $160.90.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for IRTC?

11 equities research analysts have issued 1 year price objectives for iRhythm Technologies' stock. Their forecasts range from $130.00 to $288.00. On average, they expect iRhythm Technologies' stock price to reach $217.25 in the next twelve months. This suggests a possible upside of 35.0% from the stock's current price.
View analysts' price targets for iRhythm Technologies
or view top-rated stocks among Wall Street analysts.

Who are iRhythm Technologies' key executives?

iRhythm Technologies' management team includes the following people:
  • Mr. David A. Vort, Exec. VP of Sales (Age 55, Pay $694.3k)
  • Mr. Mark J. Day Ph.D., Exec. VP of R&D (Age 50, Pay $552.89k)
  • Mr. Kevin M. King, Consultant & Director (Age 65, Pay $1.57M)
  • Mr. Matthew C. Garrett, Advisor (Age 53, Pay $826.03k)
  • Mr. Michael J. Coyle, Pres, CEO & Director (Age 59)
  • Mr. Douglas J. Devine, CFO & Sec. (Age 51)
  • Mr. Daniel G. Wilson, Exec. VP of Strategy, Corp. Devel. & Investor Relations
  • Ms. Marga Ortigas-Wedekind, Exec. VP of Marketing (Age 59)
  • Ms. Kaja J. Odegard, VP of HR (Age 39)
  • Ms. Judith C. Lenane, Chief Clinical Officer & Exec. VP of Operations (Age 62)

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies CEO Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among iRhythm Technologies' employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of iRhythm Technologies' key competitors?

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Square (SQ), Teladoc Health (TDOC), The Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and The Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include Sands Capital Management LLC (10.65%), Brown Capital Management LLC (9.43%), BlackRock Inc. (7.89%), Price T Rowe Associates Inc. MD (6.28%), Artisan Partners Limited Partnership (4.70%) and Alliancebernstein L.P. (3.59%). Company insiders that own iRhythm Technologies stock include David A Vort, Kevin M King, Mark J Day, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for iRhythm Technologies
.

Which institutional investors are selling iRhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Victory Capital Management Inc., Federated Hermes Inc., Wells Fargo & Company MN, Brown Capital Management LLC, First Trust Advisors LP, Alliancebernstein L.P., and Barclays PLC. Company insiders that have sold iRhythm Technologies company stock in the last year include David A Vort, Kevin M King, Mark J Day, Ralph Snyderman, and Raymond W Scott.
View insider buying and selling activity for iRhythm Technologies
or view top insider-selling stocks.

Which institutional investors are buying iRhythm Technologies stock?

IRTC stock was acquired by a variety of institutional investors in the last quarter, including Sands Capital Management LLC, Artisan Partners Limited Partnership, Jackson Square Partners LLC, Price T Rowe Associates Inc. MD, BlackRock Inc., Credit Suisse AG, Bessemer Group Inc., and Sei Investments Co..
View insider buying and selling activity for iRhythm Technologies
or or view top insider-buying stocks.

How do I buy shares of iRhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $160.90.

How much money does iRhythm Technologies make?

iRhythm Technologies has a market capitalization of $4.65 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis.

How many employees does iRhythm Technologies have?

iRhythm Technologies employs 997 workers across the globe.

What is iRhythm Technologies' official website?

The official website for iRhythm Technologies is www.irhythmtech.com.

Where are iRhythm Technologies' headquarters?

iRhythm Technologies is headquartered at 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.